Type D personality and cardiovascular disease: Evidence and clinical implications

Minerva Psichiatrica

Volumn 47, Issue 1, 2006, Pages 79-87

  Schiffer, A A ^a,d   Pavan, A ^a   Pedersen, S S ^a   Gremigni, P ^b   Sommaruga, M ^c   Denollet, J ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Unit of Psychology   (Italy)

^d Department of Psychology and Health   (Netherlands)

Author keywords

Cardiovascular diseases; Psychiatry; Type D personality

Indexed keywords

AFFECT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DEPRESSION; DISTRESS SYNDROME; EMOTION; FATIGUE; HEALTH STATUS; HUMAN; ITALY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERSONALITY; PROGNOSIS; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; REVIEW; RISK FACTOR; VALIDATION PROCESS;

EID: 33644759549     PISSN: 03911772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217.
2. Hemingway H, Marmot M. Psychosocial factors in the etiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999;318:1460-7.
3. Denollet J, De Potter B. Coping subtypes for men with coronary heart disease: relationship to well-being, stress, and Type A behaviour. Psychol Med 1992;22:667-84.
4. Denollet J. Bio-behavioral research on coronary heart disease: where is the person? J Behav Med 1993;16:115-41.
5. Denollet J. Personality and coronary heart disease: the Type D Scale-16 (DS16). Ann Behav Med 1998;20:209-15.
6. Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Rev 1989;96:234-54.
7. Denollet J. Type D personality a potential risk factor refined. J Psychosom Res 2000;49:255-66.
8. Asendorph JB. Social inibition: a general-developmental perspective. In: Traue HC, Pennebaker JW editors. Emotion, inibition, and health. Seattle, WA: Hografe & Huber Publishers; 1993. p. 80-99.
9. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996;347:417-21.
10. PNLG. Come produrre, diffondere e aggiornare raccomandazioni per la pratica clinica. Manuale metodologico. Milano: Arti Grafiche Passoni; 2002.
11. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med 1995;57:582-91.
12. Denollet J, Vaes J, Brutsaert DL. Inadequate response to treatment in coronary heart disease: adverse effects of Type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000;102:630-5.
13. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with decreased ejection fraction after myocardial infarction. Circulation 1998;97:167-73.
14. Denollet J. Personality and risk cancer in men with coronary heart disease. Psychol Med 1998;28:991-5.
15. Pedersen SS, Lemos PA, van Vooren PR, Liu TKK, Daemen J, Erdman RAM et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation. A Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) registry sub-study. J Am Coll Cardiol 2004;44:997-1001.
16. Appels A, Golombeck B, Gorgels A, de Vreede J, van Breuken G. Behavioral risk factors of sudden cardiac-arrest. J Psychosom Res 2000;48:463-9
17. Pedersen SS, Middel B. Increased vital exhaustion among Type D patients with ischemic heart disease. J Psychosom Res 2001;51:443-9.
18. Pedersen SS, Denollet J. Validity of Type D personality construct in Danish post-MI patients and healthy controls. J Psychosom Res 2004;57:265-72.
19. Pedersen SS, Domburg van RT, Theuns DAMJ, Jordaens L, Erdman RAM. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004;66:714-9.
20. Denollet J, Conraads VM, Brutsaert DL, De Clerck LS, Stevens WJ, Vrints CJ. Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun 2003;17:304-9.
21. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9.
22. Kiecolt-Glaser JK, McGuire L, Robles T, Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Ann Rev Psychol 2002;53:83-107.
23. Habra ME, Linden W, Anderson JC, Weinberg J. Type D personality is related to cardiovascular and neuendocrine reactivity to acute stress. J Psychosom Res 2003;55:235-45.
24. Ketterer MW, Denollet J, Goldberg AD, McCullough PA, John S, Farha AJ et al. The big mush: psychometric measures are confounded and non-independent in their association with age at initial diagnosis of ischaemic coronary heart disease. J Cardiovasc Risk 2002;9:41-8.
25. Ketterer MW, Denollet J, Chapp J, Thayer B, Keteyian S, Clark V et al. Men deny and women cry, but who dies? Do the wages of "denial" include early ischemic coronary heart disease? J Psychosom Res 2004;56:119-23.
26. Beller GA. Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities. Circulation 2001;103:2428-35.
27. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail 2000;6:225-32.
28. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 2004;110:546-51.
29. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003;42:1811-7.
30. Denollet J. Health complaints and outcome assessment in coronary heart disease. Psychosom Med 1994;56:463-74.
31. Denollet, J. Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). Psychol Med 1993;23:111-21.
32. Schiffer A, Pedersen SS, Widdershoven J, Hendriks E, Winter J, Denollet J. Type D personality is independently associated with impaired health status and increased depressive symptoms chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005;12:341-5.
33. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005;67:89-97.
34. Kopp M, Skrabski A, Csoboth C, Rethelyi J, Strauder A, Denollet J. Type D personality: cross-sectional associations with cardiovascular morbidity in the Hungarian population. Psychosom Med 2003;65 Suppl A:A64.
35. Grande G, Jordan J, Kummel M, Struwe C, Schubmann R, Schulze F et al. Evaluation of the German Type D Scale (DS14) and prevalence of the Type D personality pattern in cardiological and psychosomatic patients and healthy subjects. Psychother Psychosom Med Psychol 2004;54:413-22.
36. Gremigni P, Sommaruga M. Personalità di Tipo D, un costrutto rilevante in cardiologia. Studio preliminare di validazione del questionario italiano. Psicoterapia Cognitiva e Comportamentale 2005;11:7-18.
37. Friedman M, Rosenman RH. Association of a specific overt behaviour pattern with increases in blood colesterol, blood clotting time, incidence of arcus senilis and clinical coronary artery disease. JAMA 1959;2169:1286-96.
38. Rosenman RH, Brand RJ, Jenkins CD, Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8 1/2 years. JAMA 1975;2233:872-7.
39. Cooper T, Detre T, Weiss SM. Coronary-prone behaviour and coronary heart disease: a critical review. Circulation 1981;63:1199-215.
40. Matthews KA, Gump BB, Harris KF, Haney TL, Barefoot JC. Hostile behaviors predict cardiovascular mortality among men enrolled in the multiple risk factor intervention trial. Circulation 2004;109:66-70.
41. Dembroski TM, Costa PT. Coronary prone behaviour: components of the Type A pattern and hostility. J Pers 1987;55:211-35.
42. Temoshok L, Heller BW, Sagebiel RW, Blois MS, Sweet DM, DiClemente RJ et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res 1985;29:139-53.
43. Dimsdale JE. A perspective on Type A behaviour and coronary disease. N Engl J Med 1988;318:110-2.
44. Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999;61:476-87.
45. Kop WJ. Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity. J Psychosom Res 1997;43:167-81.
46. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT et al. for the Sertraline Antidepressant Heart Attack Randomized Trial (SAD-HEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
47. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ et al. for the Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-16.
48. Friedman M, Thoresen CE, Gill JJ, Ulmer D, Powell LH, Price VA et al. Alteration of Type A behaviour and its effect on cardiac recurrences in post myocardial infarction patients: summary of the recurrent coronary prevention project. Am Heart J 1986;112:653-55.
49. Davidson K, MacGregor MW, Stuhr J, Gidron Y. Increasing constructive anger verbal behaviour decreases resting blood pressure: a secondary analysis of a randomised controlled hostility intervention. Int J Behav Med 1999;6:268-78.
50. Linden W. Psychological treatments in cardiac rehabilitation: review of rationales and outcomes. J Psychosom Res 2000;48:443-54.
51. Denollet J, Brutsaert DL. Reducing emotional distress improves prognosis in coronary heart disease: nine-year mortality in a clinical trial of rehabilitation. Circulation 2001;104:2018-23.